Pro-Dex, Inc. (PDEX): Price and Financial Metrics
GET POWR RATINGS... FREE!
PDEX Stock Summary
- With a market capitalization of $62,498,371, Pro Dex Inc has a greater market value than only 10.91% of US stocks.
- Price to trailing twelve month operating cash flow for PDEX is currently 59.18, higher than 91.61% of US stocks with positive operating cash flow.
- With a year-over-year growth in debt of 25.68%, Pro Dex Inc's debt growth rate surpasses 76.54% of about US stocks.
- Stocks that are quantitatively similar to PDEX, based on their financial statements, market capitalization, and price volatility, are GBT, CERS, SMTC, BLI, and VIVE.
- Visit PDEX's SEC page to see the company's official filings. To visit the company's web site, go to www.pro-dex.com.
PDEX Valuation Summary
- PDEX's price/sales ratio is 2.3; this is 79.74% lower than that of the median Healthcare stock.
- PDEX's price/sales ratio has moved up 2 over the prior 243 months.
- Over the past 243 months, PDEX's EV/EBIT ratio has gone up 7.4.
Below are key valuation metrics over time for PDEX.
Stock | Date | P/S | P/B | P/E | EV/EBIT |
---|---|---|---|---|---|
PDEX | 2021-08-31 | 2.3 | 4.5 | 15.0 | 12.9 |
PDEX | 2021-08-30 | 2.4 | 4.6 | 15.3 | 13.1 |
PDEX | 2021-08-27 | 2.4 | 4.7 | 15.6 | 13.4 |
PDEX | 2021-08-26 | 2.8 | 5.5 | 18.2 | 15.4 |
PDEX | 2021-08-25 | 2.9 | 5.6 | 18.7 | 15.8 |
PDEX | 2021-08-24 | 2.9 | 5.6 | 18.6 | 15.7 |
PDEX Growth Metrics
- Its 5 year cash and equivalents growth rate is now at 201.52%.
- Its year over year price growth rate is now at 72.56%.
- The 4 year net cashflow from operations growth rate now stands at 284.52%.

The table below shows PDEX's growth in key financial areas (numbers in millions of US dollars).
Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
---|---|---|---|
2021-12-31 | 41.335 | 1.056 | 4.837 |
2021-09-30 | 39.427 | 1.511 | 4.249 |
2021-06-30 | 38.029 | -2.078 | 4.45 |
2021-03-31 | 39.718 | -0.156 | 6.142 |
2020-12-31 | 36.487 | 3.472 | 5.36 |
2020-09-30 | 36.183 | 3.149 | 6.272 |
PDEX's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- PDEX has a Quality Grade of C, ranking ahead of 55.91% of graded US stocks.
- PDEX's asset turnover comes in at 1.002 -- ranking 19th of 186 Medical Equipment stocks.
- APEN, ZBH, and BDX are the stocks whose asset turnover ratios are most correlated with PDEX.
The table below shows PDEX's key quality metrics over time.
Period | Asset Turnover | Gross Margin | ROIC |
---|---|---|---|
2021-06-30 | 1.002 | 0.357 | 0.150 |
2021-03-31 | 1.114 | 0.371 | 0.230 |
2020-12-31 | 1.136 | 0.372 | 0.237 |
2020-09-30 | 1.217 | 0.382 | 0.312 |
2020-06-30 | 1.201 | 0.377 | 0.316 |
2020-03-31 | 1.112 | 0.371 | 0.260 |
PDEX Price Target
For more insight on analysts targets of PDEX, see our PDEX price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
Average Price Target | $39.00 | Average Broker Recommendation | 1.5 (Moderate Buy) |
PDEX Stock Price Chart Interactive Chart >
PDEX Price/Volume Stats
Current price | $16.21 | 52-week high | $32.00 |
Prev. close | $15.95 | 52-week low | $12.40 |
Day low | $15.56 | Volume | 4,629 |
Day high | $16.25 | Avg. volume | 9,156 |
50-day MA | $15.40 | Dividend yield | N/A |
200-day MA | $20.42 | Market Cap | 58.66M |
Pro-Dex, Inc. (PDEX) Company Bio
Pro-Dex, Inc. products and distributes medical and dental equipment. The Company offers micro-air motors, surgical drivers, and precision air powered motors. Pro-Dex markets its products in the United States.
Latest PDEX News From Around the Web
Below are the latest news stories about Pro Dex Inc that investors may wish to consider to help them evaluate PDEX as an investment opportunity.
What Is Pro-Dex, Inc.'s (NASDAQ:PDEX) Share Price Doing?Pro-Dex, Inc. ( NASDAQ:PDEX ), is not the largest company out there, but it received a lot of attention from a... |
Pro-Dex, Inc. Discusses 2nd Quarter Sales and New Product Development with The Stock Day PodcastPhoenix, Arizona--(Newsfile Corp. - February 24, 2022) - The Stock Day Podcast welcomed Pro-Dex, Inc. (NASDAQ: PDEX) ("the Company"), a company that specializes in the design, development, and manufacture of autoclavable, battery-powered and electric, multi-function surgical drivers and shavers used primarily in the orthopedic, thoracic, and maxocranial facial markets. President and CEO of the Company, Rick Van Kirk, joined Stock Day host Everett Jolly. Jolly began the interview by asking about |
Pro-Dex (NASDAQ:PDEX) shareholders have earned a 36% CAGR over the last five yearsLong term investing can be life changing when you buy and hold the truly great businesses. And we've seen some truly... |
Pro-Dex, Inc. Announces Fiscal 2022 Second Quarter and Six-Month ResultsIRVINE, CA / ACCESSWIRE / February 3, 2022 / PRO-DEX, INC. (NASDAQ:PDEX) today announced financial results for its fiscal 2022 second quarter ended December 31, 2021. |
Pro-Dex, Inc.'s (NASDAQ:PDEX) Stock Is Going Strong: Is the Market Following Fundamentals?Most readers would already be aware that Pro-Dex's (NASDAQ:PDEX) stock increased significantly by 13% over the past... |
PDEX Price Returns
1-mo | 2.21% |
3-mo | 0.06% |
6-mo | -30.16% |
1-year | -48.21% |
3-year | 23.93% |
5-year | 163.58% |
YTD | -30.16% |
2021 | -25.06% |
2020 | 76.47% |
2019 | 45.28% |
2018 | 77.65% |
2017 | 44.68% |
Continue Researching PDEX
Want to do more research on Pro Dex Inc's stock and its price? Try the links below:Pro Dex Inc (PDEX) Stock Price | Nasdaq
Pro Dex Inc (PDEX) Stock Quote, History and News - Yahoo Finance
Pro Dex Inc (PDEX) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...